NasdaqCM - Nasdaq Real Time Price USD
Veru Inc. (VERU)
0.5035
-0.0186
(-3.56%)
At close: May 9 at 4:00:00 PM EDT
0.5200
+0.02
+(3.28%)
After hours: May 9 at 7:36:40 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | -- | -- |
| Avg. Estimate | -0.05 | -0.05 | 0 | 0 |
| Low Estimate | -0.05 | -0.05 | 0 | 0 |
| High Estimate | -0.05 | -0.05 | 0 | 0 |
| Year Ago EPS | -0.08 | -0.05 | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 3.95M | 6.66M | 16.89M | -- |
| Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.06 | -0.08 | -0.08 | -0.05 |
| EPS Actual | -0.08 | -0.05 | -0.07 | -0.06 |
| Difference | -0.02 | 0.03 | 0.01 | -0.01 |
| Surprise % | -26.67% | 35.00% | 10.87% | -20.60% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.05 | -0.05 | 0 | 0 |
| 7 Days Ago | -0.05 | -0.05 | 0 | 0 |
| 30 Days Ago | -0.05 | -0.05 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VERU | 34.21% | 3.85% | -- | -- |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/20/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 11/5/2024 |
| Initiated | B. Riley Securities: Buy | 5/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/6/2024 |
Related Tickers
ALXO ALX Oncology Holdings Inc.
0.4223
-8.24%
FGEN FibroGen, Inc.
0.3080
-3.57%
SGMO Sangamo Therapeutics, Inc.
0.7002
-2.72%
MGNX MacroGenics, Inc.
1.4300
-7.14%
CDT Conduit Pharmaceuticals Inc.
0.4000
0.00%
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
VTYX Ventyx Biosciences, Inc.
1.2400
+5.98%
NKTR Nektar Therapeutics
0.5887
-4.88%
XERS Xeris Biopharma Holdings, Inc.
5.01
-2.91%
SAVA Cassava Sciences, Inc.
1.7700
+4.12%